Effectiveness of Intra-Arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma: Relevance of a Multidisciplinary Setting

被引:2
作者
Castela, Guilherme [1 ,2 ,3 ,7 ]
Providencia, Joana [1 ,2 ]
Monteiro, Madalena [1 ]
Oliveiros, Barbara [2 ]
Silva, Sonia [4 ]
Brito, Manuel [4 ]
Machado, Egidio [5 ]
Murta, Joaquim Neto [1 ,2 ]
Castelo-Branco, Miguel [2 ,3 ]
Correa, Zelia [6 ]
机构
[1] Ctr Hosp & Univ Coimbra, Dept Ophthalmol, Coimbra, Portugal
[2] Univ Coimbra FMUC, Fac Med, Coimbra, Portugal
[3] Coimbra Inst Biomed Imaging & Translat Res CIBIT, Coimbra, Portugal
[4] Ctr Hosp & Univ Coimbra, Dept Pediat Oncol, Coimbra, Portugal
[5] Ctr Hosp & Univ Coimbra, Dept Med Imaging, Coimbra, Portugal
[6] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA
[7] Ctr Hosp & Univ Coimbra, Dept Ophthalmol, Praceta Prof Mota Pinto, P-3004561 Coimbra, Portugal
来源
CLINICAL OPHTHALMOLOGY | 2023年 / 17卷
关键词
retinoblastoma; intra-arterial chemotherapy; ocular oncology; pediatric oncology; OPHTHALMIC ARTERY CHEMOTHERAPY; BILATERAL RETINOBLASTOMA; MANAGEMENT; MELPHALAN; SEEDS;
D O I
10.2147/OPTH.S398488
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: We aim to report about effectiveness and safety in the context of our centers' setting in the management of retinoblastoma with intra-arterial chemotherapy (IAC) in a 5-year retrospective analysis of the Portuguese population. Patients and Methods: Retrospective analysis of consecutive cases of retinoblastoma selected to initiate IAC between 2015 and 2020, at the Portuguese National Reference Center. All included patients underwent complete ophthalmological evaluation under anesthesia with fundus photography. Diagnosis and classification of retinoblastoma was made according to the International Classification of Intraocular Retinoblastoma (ICRB). The patients were further divided into two groups: Group I for primary IAC and Group II for secondary IAC. Tumor recurrence or relapses, systemic metastasis and deaths were documented. Main efficacy outcome included ocular salvage and recurrence-free survival rates estimated using the Kaplan-Meier method.Results: Twenty-eight eyes (19 eyes included in Group I and 9 eyes included in Group II) were eligible and a total of 130 IAC procedures were performed, with a median number of sessions of 4 (range 1-8) for each treated eye, during a median follow-up of 21 months (range 4-64). Of the included eyes, 22 (78.6%) were preserved. An overall survival of 100% was achieved. Considering the preserved eyes, the overall median decimal visual acuity achieved at the last visit was 0.15 (range 0.02-0.8). Three patients had permanent adverse events related to IAC (cataract, vitreous hemorrhage and choroidal ischemia). Considering the survival analysis of recurrence, the mean survival without recurrence was 84.2% for Group I and 66.7% for Group II, and the mean survival without enucleation was 78.6% (no events in Group II).Conclusion: IAC has been shown to be an effective and safe treatment for children with intraocular retinoblastoma. This study demonstrates that IAC is effective even in moderate sample sizes, when a multidisciplinary approach is available.
引用
收藏
页码:487 / 496
页数:10
相关论文
共 31 条
  • [1] A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma - Initial results
    Abramson, David H.
    Dunkel, Ira J.
    Brodie, Scott E.
    Kim, Jonathan W.
    Gobin, Y. Pierre
    [J]. OPHTHALMOLOGY, 2008, 115 (08) : 1398 - 1404
  • [2] Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy)
    Abramson, David H.
    Marr, Brian P.
    Francis, Jasmine H.
    Dunkel, Ira J.
    Fabius, Armida W. M.
    Brodie, Scott E.
    Mondesire-Crump, Ijah
    Gobin, Y. Pierre
    [J]. PLOS ONE, 2016, 11 (06):
  • [3] Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC
    Abramson, David H.
    Fabius, Armida W. M.
    Issa, Reda
    Francis, Jasmine H.
    Marr, Brian P.
    Dunkel, Ira J.
    Gobin, Y. Pierre
    [J]. PLOS ONE, 2015, 10 (12):
  • [4] Treatment of Retinoblastoma in 2015 Agreement and Disagreement
    Abramson, David H.
    Shields, Carol L.
    Munier, Francis L.
    Chantada, Guillermo L.
    [J]. JAMA OPHTHALMOLOGY, 2015, 133 (11) : 1341 - 1347
  • [5] Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results
    Abramson, David H.
    Marr, Brian P.
    Dunkel, Ira J.
    Brodie, Scott
    Zabor, Emily C.
    Driscoll, Sarah J.
    Gobin, Y. Pierre
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (04) : 499 - 502
  • [6] Superselective Ophthalmic Artery Chemotherapy as Primary Treatment for Retinoblastoma (Chemosurgery)
    Abramson, David H.
    Dunkel, Ira J.
    Brodie, Scott E.
    Marr, Brian
    Gobin, Y. Pierre
    [J]. OPHTHALMOLOGY, 2010, 117 (08) : 1623 - 1629
  • [7] Bilateral Superselective Ophthalmic Artery Chemotherapy for Bilateral Retinoblastoma: Tandem Therapy
    Abramson, David H.
    Dunkel, Ira J.
    Brodie, Scott E.
    Marr, Brian
    Gobin, Y. Pierre
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (03) : 370 - 372
  • [8] Adjunctive techniques for optimization of ocular hemodynamics in children undergoing ophthalmic artery infusion chemotherapy
    Abruzzo, Todd A.
    Geller, James I.
    Kimbrough, Dale A.
    Michaels, Samantha
    Correa, Zelia M.
    Cornell, Kevin
    Augsburger, James J.
    [J]. JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2015, 7 (10) : 770 - 776
  • [9] Aziz Hassan A, 2010, Retina, V30, pS63, DOI 10.1097/IAE.0b013e3181cbda0f
  • [10] Brodie SE, 2015, J PROTEOM, V130, P180, DOI [10.1016/j.jprot.2015.09.027, DOI 10.1016/J.JPROT.2015.09.027]